Skip to content
healthcare.dev
Get a free key

Buprenorphine and Naloxone

NDC 0228-3154, Buprenorphine and Naloxone, tablet, from Actavis Pharma, Inc..

Product NDC
0228-3154
Status
Listed
Labeler
Actavis Pharma, Inc.
Dosage form
TABLET
Route
SUBLINGUAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA091422
DEA schedule
CIII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0228-3154 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPRENORPHINE HYDROCHLORIDE2 mg/1
  • NALOXONE HYDROCHLORIDE DIHYDRATE.5 mg/1

Pharmacologic classes

Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]

Package NDCNDC-11Package
0228-3154-030022831540330 TABLET in 1 BOTTLE (0228-3154-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6cccf229-9611-4b6f-8f1b-acc8ff1ed3f8

  • NADAC price for package 00228315403

    GET /v1/drugs/nadac/00228315403

Use it

Look up 0228-3154 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0228-3154 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0228-3154. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.